The gefitinib probe was applied together with an oligonucleotide-conjugated anti-EGF receptor-specific antibody probe both in fixed A431 cells and in fresh-frozen breast cancer tissues scored as grade +3 HER2 positive (Figure 5C, D and Supplementary Figure S14a). This evidence concerns the gene ERBB2 and breast cancer.